Show simple item record

dc.contributor.authorWilkes, Dennis K.
dc.contributor.authorDe Vries, Armand
dc.contributor.authorOliver, Douglas W.
dc.contributor.authorMalan, Sarel F.
dc.date.accessioned2010-02-08T11:10:39Z
dc.date.available2010-02-08T11:10:39Z
dc.date.issued2009
dc.identifier.citationWilkes, D.K. et al. 2009. Nitric oxide syntase inhibition by pentacycloundecane conjugates of aminoguanidine and tryptamine. Archiv der Pharmazie, 342(2):73-79. [https://doi.org/10.1002/ardp.200800198]en
dc.identifier.issn0365-6233
dc.identifier.issn1521-4184 (Online)
dc.identifier.urihttp://hdl.handle.net/10394/2825
dc.identifier.urihttps://doi.org/10.1002/ardp.200800198
dc.identifier.urihttps://onlinelibrary.wiley.com/doi/abs/10.1002/ardp.200800198
dc.description.abstractThis paper describes the synthesis and in-vitro activity of pentacycloundecane-conjugated aminoguanidine and tryptamine analogues on nitric oxide synthase (NOS) using rat brain homogenate. Both aminoguanidine and tryptamine-derived NOS inhibitors show selectivity towards the inducible and neuronal isoforms of the NOS enzyme, but are weak inhibitors and complete inhibition of the enzyme occurs only at high millimolar concentrations. In view of the increased NOS inactivation observed with alkyl substitution of these structures, the present study aimed to evaluate the effect of the pentacycloundecane cage moiety as an alkyl substituent on the in vitro NOS inhibition of aminoguanidine and tryptamine compounds. Comparison of the IC50 values of aminoguanidine (IC50 = 2.306610–3 M) and 8-imino-N-guanidino-pentacyclo-undecane 2 (IC50 = 8.803610– 5 M) revealed a more than 26-fold increase in potency. The ability of tryptamine to inhibit NOS activity was also markedly improved by the various pentacycloundecane substituents. The compounds, 3-hydroxy-4-[3-(2-aminoethyl)indole]-azahexacyclo[5.4.1.02,6.03,10.05,9.08,11]dodecane 4 and 8-[3-(2-aminoethyl) indole]-pentacyclo[5.4.02,6.03,10.05,9]undecane 7 showed the best activity of the tryptamine analogues with a more than 3-fold increase in nitric oxide synthase inhibition. The results confirmed that the pentacycloundecane structure substantially enhanced the NOS inhibitory potency as observed for the six new NOS inhibitors
dc.language.isoenen
dc.publisherWiley
dc.subjectAminoguanidine
dc.subjectNitric oxide synthase
dc.subjectPentacycloundecane
dc.subjectTryptamine
dc.titleNitric oxide syntase inhibition by pentacycloundecane conjugates of aminoguanidine and tryptamineen
dc.typeArticleen
dc.contributor.researchID10060855 - Oliver, Douglas William
dc.contributor.researchID10199667 - Malan, Sarel Francois


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record